Aidoc vs Hippocratic AI
In-depth comparison — valuation, funding, investors, founders & more
🇮🇱 Israel · Elad Walach
Valuation
N/A
Total Funding
$370M
300 employees
🇺🇸 United States · Munjal Shah
Valuation
N/A
Total Funding
$120M
50-200 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both Aidoc and Hippocratic AI compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Aidoc is an Israeli artificial intelligence company founded in 2016 that develops clinical decision support software for radiology and medical imaging. Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up.
Neither company has publicly disclosed a valuation at this time. On the funding side, Aidoc has raised $370M in total — $250M more than Hippocratic AI's $120M.
Aidoc has 7 years more market experience, having been founded in 2016 compared to Hippocratic AI's 2023 founding. In terms of growth stage, Aidoc is at Series D while Hippocratic AI is at Series B — a meaningful difference for investors evaluating risk and upside.
Aidoc operates out of 🇮🇱 Israel while Hippocratic AI is based in 🇺🇸 United States, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, both companies are closely matched — Aidoc scores 67 and Hippocratic AI scores 65.
Metrics Comparison
| Metric | Aidoc | Hippocratic AI |
|---|---|---|
💰Valuation | N/A | N/A |
📈Total Funding | $370MWINS | $120M |
📅Founded | 2016 | 2023WINS |
🚀Stage | Series D | Series B |
👥Employees | 300 | 50-200 |
🌍Country | Israel | United States |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 67WINS | 65 |
Key Differences
Funding gap: Aidoc has raised $250M more ($370M vs $120M)
Market experience: Aidoc has 7 years more (founded 2016 vs 2023)
Growth stage: Aidoc is at Series D vs Hippocratic AI at Series B
Team size: Aidoc has 300 employees vs Hippocratic AI's 50-200
Market base: 🇮🇱 Aidoc (Israel) vs 🇺🇸 Hippocratic AI (United States)
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Aidoc scores 67/100 vs Hippocratic AI's 65/100
Which Should You Choose?
Use these signals to make the right call
Choose Aidoc if…
Top Pick- ✓Higher Awaira Score — 67/100 vs 65/100
- ✓Stronger investor backing — raised $370M
- ✓More market experience — founded in 2016
- ✓Israel-based for regional compliance or proximity
- ✓Aidoc is an Israeli artificial intelligence company founded in 2016 that develops clinical decision support software for radiology and medical imaging
Choose Hippocratic AI if…
- ✓United States-based for regional compliance or proximity
- ✓Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up
Funding History
Aidoc raised $370M across 8 rounds. Hippocratic AI raised $120M across 0 rounds.
Aidoc
Series D
Dec 2021
Lead: Insight Partners
Series D
Jun 2021
Lead: Macquarie Group
Series C
Sep 2020
Lead: Khosla Ventures
Series C
Sep 2020
Lead: Ibex Investors
Series B
Jan 2019
Lead: GE Ventures
Series B
Jan 2019
Lead: Khosla Ventures
Series A
Jan 2018
Series A
Jan 2018
Lead: Pitango VC
Hippocratic AI
No public funding data available.
Investor Comparison
No shared investors detected between these two companies.
Unique to Aidoc